Encapsulated papillary thyroid carcinoma, follicular variant: A misnomer

Pathology International

Volumn 62, Issue 3, 2012, Pages 155-160

  Kakudo, Kennichi ^a,b   Bai, Yanhua ^c   Liu, Zhiyan ^d   Ozaki, Takashi ^b  

^a KOBE TOKIWA UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^d SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Borderline malignancy; Diagnosis; Follicular variant papillary carcinoma; Thyroid gland; Treatment

Indexed keywords

ACCESSORY NERVE INJURY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER MORPHOLOGY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CELL INCLUSION; CELL NUCLEUS; CELL NUCLEUS GROOVE; CELL SHAPE; DNA MICROARRAY; FACIAL NERVE PARALYSIS; FOLLOW UP; GROUND GLASS CELL NUCLEUS; HORNER SYNDROME; HUMAN; HYPOPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; LARYNGEAL NERVE INJURY; LOBECTOMY; METASTASIS; NECK DISSECTION; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE PALSY; REOPERATION; REVIEW; THYROID FOLLICULAR CARCINOMA; THYROID SURGERY; THYROIDECTOMY;

CARCINOMA, PAPILLARY, FOLLICULAR; HUMANS; THYROID NEOPLASMS;

EID: 84862792483     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02773.x     Document Type: Review

References (53)

1. Vickery AL. Thyroid papillary carcinoma: Pathological and philosophical controversies. Am J Surg Pathol 1983; 7: 797-803.
2. Chan JK. Papillary carcinoma of thyroid: Classical and variants. Histol Histopathol 1990; 5: 241-57.
3. Rosai J, Carcangiu ML, DeLellis RA. Atlas of Tumor Pathology, Third Series Fascicle 5, Tumors of the Thyroid Gland. Washington DC: American Registry of Pathology, Armed Forces Institute of Pathology, 1992; 65-121.
4. DeLellis RA, Lloyd RV, Heitz PU, Eng C. Tumours of Endocrine Organs, World Health Organization Classification of Tumours; Pathology and Genetics. Lyon: IARC Press, 2004; Chapter 2 Tumours of the thyroid and parathyroid, pp49-134 and Chapter 4 Tumours of the endocrine pancreas, pp175-208.
5. Chen KT, Rosai J. Follicular variant of thyroid papillary carcinoma: A clinicopathologic study of six cases. Am J Surg Pathol 1977; 1: 123-30.
6. Rosai J. The encapsulated follicular variant of papillary thyroid carcinoma: Back to the drawing board. Endocr Pathol 2010; 21: 7-11.
7. Kakudo K, Katoh R, Sakamoto A etal. Thyroid gland: International case conference. Endocr Pathol 13: 131-4, 2002.
8. Hirokawa M, Carney JA, Goellner JR etal. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 2002; 26: 1508-14.
9. Lloyd RV, Erickson LA, Casey MB etal. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 2004; 28: 1336-40.
10. Elsheikh TM, Asa SL, Chan JK etal. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol 2008; 130: 683-6.
11. Baloch ZW, LiVolsi VA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol 2000; 13: 861-5.
12. Kahn A, Nose V. Pathology of thyroid gland. In: Lloyd RV, ed. Endocrine Pathology, Differential Diagnosis and Molecular Advances. New York: Springer, 2010; 181-236.
13. Liu J, Singh B, Tallini G etal. Follicular variant of papillary carcinoma. A clinicopathologic study of a problematic entity. Cancer 2006; 107: 1255-64.
14. Rivera M, Tuttle M, Patel S etal. Encapsulated papillary thyroid carcinoma: A clinic-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid 2009; 19: 119-27.
15. Kakudo K, Bai Y, Katayama S etal. Classification of follicular cell tumors of the thyroid gland: Analysis involving Japanese patients from one institute. Pathol Int 2009; 59: 359-67.
16. Liu Z, Zhou G, Nakamura M etal. Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: A morphological, immunohistochemical, and molecular appraisal. Cancer Sci 2011; 102: 288-94.
17. Hofman V, Lassalle S, Bonnetaud C etal. Thyroid tumours of uncertain malignant potential: Frequency and diagnostic reproducibility. Virchows Arch 2009; 455: 21-33.
18. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: The WHO classification. Ann N Y Acad Sci 2004; 1014: 13-27.
19. Williams ED. Guest Editorial: Two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 2000; 8: 181-3.
20. Tielens ET, Sherman SI, Hruban RH etal. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 1994; 73: 424-31.
21. Zidan J, Karen D, Stein M etal. Pure versus follicular variant of papillary thyroid carcinoma: Clinical features, prognostic factors, treatment, and survival. Cancer 2003; 97: 1181-5.
22. Widder S, Guggisberg K, Khalil M etal. A pathologic re-review of follicular thyroid neoplasms: The impact of changing the threshold for the diagnosis of follicular variant of papillary thyroid carcinoma. Surgery 2008; 144: 80-85.
23. Chan JKC. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary carcinoma. Am J Clin Pathol 2002; 117: 16-8.
24. Renshow A, Gould WG. Why there is the tendency to 'overdiagnose' the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 2002; 117: 19-21.
25. Piana S, Frasoldai A, Felice ED etal. Encapsulated well-differentiated follicular-patterned thyroid carcinoma do not play a significant role in the fatality rate from thyroid carcinoma. Am J Surg Pathol 2010; 34: 868-72.
26. Passler C, Prager G, Scheuba C etal. Follicular variant of papillary thyroid carcinoma: A long-term follow-up. Ann Surg 2003; 138: 1362-6.
27. Lin HW, Bhattacharyya N. Clinical behavior of follicular variant of papillary thyroid carcinoma: Presentation and survival. Laryngoscope 2010; 120: 712-6.
28. Scognamiglio T, Hyjek E, Kao J etal. Diagnostic usefulness of HBME1, Galectin-3, CK18, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. Am J Clin Pathol 2006; 126: 700-708.
29. Kakudo K, Tang W, Ito Y etal. Papillary carcinoma of the thyroid in Japan: Subclassification of common type and identification of low risk group. J Clin Pathol 2004; 57: 1041-6.
30. Kakudo K, Bai Y, Liu Z etal. Classification of thyroid follicular cell tumors: With special reference to borderline lesions. Endocr J 2012; 59: 1-12.
31. VanHeerden JA, Hay ID, Goellner JR etal. Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy. Surgery 1992; 112: 1130-38.
32. Ito Y, Hirokawa M, Higashiyama T etal. Prognosis and prognostic factors of follicular carcinoma in Japan: Importance of postoperative pathological examination. World J Surg 2007; 31: 1417-24.
33. Sobrinho-Simoes M, Eloy C, Magalhaes J etal. Follicular thyroid carcinoma. Mod Pathol 2011; 24: s10-18.
34. Collini P, Sampietro G, Pilotti S. Extensive vascular invasion is a marker of risk of relapse in encapsulated non-Hurthle cell follicular carcinoma of the thyroid gland: A clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up. Histopathology 2004; 44: 35-9.
35. Ghossein RA, Hiltzik DH, Carlson DL etal. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: A clinicopathologic study of 50 cases. Cancer 2006; 106: 1669-76.
36. Shaha AR, Ferlito A, Rinaldo A. Distant metastasis from thyroid and parathyroid cancer. ORL J Otorhinolaryngol Relat Spec 2001; 63: 243-9.
37. Lee J, Soh EY. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors. Ann Surg 2010; 251: 114-9.
38. Song H, Xue YL, Xu Y, Qiu Z, Luo Q. Rare metastases of differentiated thyroid carcinoma: Pictorial review. Endocr Relat Cancer 2011; 18: 165-75.
39. Ito Y, Hirokawa M, Uruno T etal. Biological behavior and prognosis of encapsulated papillary carcinoma of the thyroid: Experience of a Japanese Hospital for thyroid care. World J Surg 2008; 32: 1789-94.
40. Zhu Z, Gandhi M, Nikiforova MN etal. Molecular profile and clinico-pathologic features of the follicular variant of papillary carcinoma. An usually high prevalence of ras mutations. Am J Clin Pathol 2003; 120: 71-7.
41. Finley DJ, Arora N, Zhu B etal. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab 2004; 89: 3214-23.
42. Adeniran AJ, Zhu Z, Gandhi M etal. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 2006; 30: 216-22.
43. Castro P, Rebocho AP, Soares RJ etal. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 2006; 91: 213-20.
44. Pita JM, Banito A, Cavaco BM etal. Gene expression profiling associated with the progression to poorly differentiated thyroid carcinoma. Br J Cancer 2009; 101: 1782-91.
45. Santarpia L, Myers JN, Sherman SI etal. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma. Cancer 2010; 116: 2974-83.
46. Fontaine JF, Mirebeau-Pruiner D, Franc B etal. Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy. Oncogene 2008; 27: 2228-36.
47. Arora N, Scognamiglio T, Lubitz CC etal. Identification of borderline thyroid tumors by gene expression array analysis. Cancer 2009; 115: 5421-31.
48. Prasad ML, Pellegata NS, Huang Y etal. Galectin-3, fibronectin-1, CITED-1, HBME-1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 2005; 18: 48-57.
49. Liu YY, Morreau H, Kievit J etal. Combined immunostaining with galectin-3, fibronectin-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-gamma, and sodium/iodine symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma. Eur J Endocrinol 2008; 158: 375-84.
50. Nakamura N, Erickson LA, Jin L etal. Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma. Endocr Pathol 2006; 17: 213-23.
51. Torregrossa L, Faviana P, Camacci T etal. Galectin-3 is highly expressed in encapsulated papillary thyroid carcinoma but weakly expressed in capsulated type; comparison with Hector Battifora mesothelial cell-1 immunoreactivity. Hum Pathol 2007; 38: 1482-8.
52. Papotti M, Rodriguez J, De Pompa R etal. Galectin-3 and HBME-1 expression in well differentiated thyroid tumors with follicular architecture of uncertain malignant potential. Mod Pathol 2005; 18: 541-6.
53. Coli A, Bigotti G, Parente P etal. Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma. J Exp Clin Cancer Res 2007; 26: 221-7.